NTR Total Non-Current Assets

Nutrien Ltd. Common Shares · Total Non-Current Assets

NTR logo

NTR Total Non-Current Assets

Latest reported$37.39B
NTR Quarterly Non-Current Assets ($959.40M → $37.39B)
High-resolution chart · PNG

NTR total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nutrien Ltd. Common Shares Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
37,388,000,000
37,571,159,000
37,483,661,000
37,352,000,000
37,640,000,000
37,707,000,000
38,048,000,000
38,037,000,000
37,903,000,000
38,425,000,000
38,579,000,000
38,137,000,000
37,930,000,000
38,321,000,000
38,244,000,000
37,128,000,000
36,578,000,000
36,243,000,000
36,108,000,000
35,634,000,000
35,479,000,000
35,418,000,000
35,722,000,000
35,390,000,000
36,031,000,000
35,843,000,000
36,134,000,000
35,705,000,000
35,161,000,000
35,199,000,000
33,840,000,000
33,551,000,000
35,011,000,000
34,737,000,000
13,675,000,000
15,829,000,000
15,813,000,000
15,841,000,000
15,861,000,000
15,841,000,000
15,776,000,000
15,906,000,000
15,916,000,000
15,773,000,000
16,040,000,000
15,936,000,000
15,786,000,000
15,641,000,000
15,771,000,000
15,762,000,000
15,769,000,000
15,636,000,000
15,659,000,000
16,157,000,000
15,710,000,000
15,120,000,000
14,292,000,000
14,217,000,000
13,849,000,000
13,482,000,000
13,901,000,000
13,584,000,000
13,452,000,000
12,557,000,000
11,096,600,000
11,541,500,000
10,650,500,000
9,672,600,000
9,043,600,000
8,389,300,000
7,981,600,000
8,537,300,000
9,860,600,000
8,411,600,000
7,905,300,000
6,973,400,000
6,521,300,000
6,149,200,000
4,906,800,000
4,568,400,000
4,503,400,000
4,447,900,000
4,247,100,000
4,150,700,000
3,985,600,000
3,879,600,000
3,883,200,000
3,762,000,000
3,758,700,000
3,794,400,000
3,833,400,000
3,607,800,000
3,805,100,000
3,834,800,000
3,853,600,000
3,833,300,000
3,817,700,000
3,783,000,000
3,777,700,000
3,627,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.